CRL

Charles River Laboratories International, Inc. (NYSE:CRL) is a leading contract research organization founded in 1947 and headquartered in Wilmington, Massachusetts. The company went public in 2000 and has grown to become one of the world's largest providers of non-clinical drug development services to the pharmaceutical and biotechnology industries. Charles River operates globally across the United States, Europe, Canada, and the Asia Pacific region, serving as a critical partner in the drug discovery and development process by providing essential testing services, research models, and manufacturing solutions that help bring new medicines to market.